About VIB (116)
Bio imaging core (1)
Business opportunities (16)
Cardiovascular medicine (25)
Cell biology (16)
Developmental biology (6)
Inflammation and immunity (52)
International PhD Program (1)
Model Organisms (2)
Plant biology (91)
Research Areas (5)
Science ethics (2)
Structural biology (24)
Systems biology (7)
BioInformatics Training and Service facility (1)
Research services (5)
Page Content Zone 1
Receive VIB press releases
Follow us on Twitter
Like us on Facebook
For all press inquiries, contact
Tel.: +32 9 244 66 11
Recent press releases
Most cited article published in Cell Death & Disease is from the Peter Vandenabeele lab (VIB/UGent)
28 August 2015
The journal Cell Death & Disease gives an overview of their most cited papers. N°1 in Europe is one from the group of Peter Vandenabeele.
VIB n°1 in patent citations in survey the times - Most "innovative" universities
26 August 2015
In a survey done by The Times on most innovative universities VIB ranks 1st in patent citations. Johan Cardoen (managing director VIB): ‘This is a great result and a very nice proof that the VIB model works.’
Various avenues to counteract TNF - crucial to tackling acute inflammation
25 August 2015
The cytokine TNF plays and important role in acute inflammation and in a number of auto-immune conditions. TNF needs to pass on a signal in order to execute its role. This can be achieved by binding to a receptor.
New insights in pathological mechanism that causes dysfunctional synapses
20 August 2015
Genetic analysis of human patients has shown that mutations in genes involved in synaptic communication can drive neuropsychiatric and neurological diseases such as autism spectrum disorder and Alzheimer’s disease.
Reducing resistance to chemotherapy in colorectal cancer by inhibition of PHD1
19 August 2015
Scientists at VIB and KU Leuven have shown that blocking the PHD1 oxygen sensor hinders the activation of p53, a transcription factor that aids colorectal cancer (CRC) cells in repairing themselves and thus resisting chemotherapy.
Scientific results of the potato field trials in Flanders and the Netherlands demonstrate that gene stacking is necessary for a strong and lasting resistance to Phytophthora blight.
17 August 2015
Flemish researchers from Ghent University, VIB, ILVO and Wageningen University & Research Centre have now published the results of their field research in the journal Crop Protection.
Polyglutamine repeats play key role in functional development of cells
11 August 2015
Scientists at VIB and KU Leuven have revealed that variable polyglutamine repeats in the DNA tune the function of the protein in which they reside. To date, these repeats were known only to cause severe neurodegenerative diseases such as Huntington’s.
Two papers in Nature revealing the receptor activation mechanism for opioid and morphinan analgesics
5 August 2015
Jan Steyaert: 'This knowledge may pave the way to new morphine-like pain killers with fewer side effects.'
Blocking the PHD2 oxygen sensor inhibits breast cancer dissemination
30 July 2015
Scientists at VIB and KU Leuven have shown that reducing the expression of the PHD2 oxygen sensor impairs the ability of breast cancers to metastasize (spread) to other parts of the body.
Investigators at VIB and UGent have developed a tool for more accurate interpretation of biomedical research
23 July 2015
The research group of Prof Peter Vandenabeele (VIB/UGent) recently used tangible examples to demonstrate how the side effects of genetic modification of mice can complicate the interpretation of biomedical research.
Peter Carmeliet is bestowed the title of baron
22 July 2015
With the appointment of seven barons, three baronesses, three knights and an earl, King Philip has raised fourteen people into peerage.
Potential target pathway may pave the way for new therapeutic approaches for fragile X syndrome and autism
16 July 2015
The discovery that it might also contribute to FXS, a neurodevelopmental disorder occurring at a young age, is remarkable.
Researchers at VIB, ULB, KU Leuven uncover new genetic alterations in development of skin cell carcinoma
13 July 2015
“These results will be the foundation of many future studies on the genetic aberrations controlling cancer development” - Diether Lambrechts, VIB-KU Leuven
Genome Engineering and Synthetic Biology - Tools and Technologies - 2nd edition
13 July 2015
Genome Engineering and Synthetic Biology are revolutionizing Life Sciences. We are pleased to announce the 2nd edition of GESB in January, 2016.
Applied Bioinformatics in Life Sciences
13 July 2015
We are delighted to invite you to the VIB Conference “Applied Bioinformatics in life sciences” in the historical center of Leuven (Belgium) on March 17-18, 2016.
Page Content Zone 2
Page Content Zone 3
Inflammation and immunity
Training and facilities
Int. Ph.D. Program